Glaucoma stent approved

June 26, 2012
Glaucoma stent approved

(HealthDay) -- An ocular stent that's designed to reduce inner-eye pressure among people with mild or moderate open-angle glaucoma has been approved by the U.S. Food and Drug Administration.

The iStent Trabecular Micro-Bypass Stent System is sanctioned for people with the disease who also have a cataract. The stent, along with surgery to remove the cataract, is designed to prevent damage to the caused by high pressure inside the eye. Open-angle glaucoma, which causes this build-up of pressure, is among the leading causes of vision loss and blindness, the FDA said in a news release.

The iStent is a small titanium tube that's designed to restore the natural draining of fluid from the eye, potentially decreasing intraocular pressure. The device was clinically studied among 239 people. Because the stent was used in cases where also was performed, complications -- including the stent becoming blocked -- could not be attributed solely to either the stent or the surgery, the agency said.

The iStent system is manufactured by Glaukos Corp., based in Laguna Hills, Calif.

Explore further: Boston Scientific admits stent risks

More information: Medline Plus has more about glaucoma.


Related Stories

Boston Scientific admits stent risks

September 7, 2006

The U.S.-based Boston Scientific Corp. has admitted there is an increased risk of blood clots caused by use of its drug-coated cardiac stent.

Abbott expanding study of its popular Xience stent

August 13, 2009

(AP) -- Abbott Laboratories Inc. is expanding a study of its top-selling heart stent by more than 2,000 patients, who may also be put in a second, landmark stent study meant to find the best way to prevent potentially fatal ...

After 55 years, surgery restores sight

June 17, 2011

After being hit in the eye by a stone, a detached retina left a man blind in his right eye. Despite surgery to remove a cataract when the man was 23, which temporarily restored light perception, the patient was completely ...

A new stent design may put patients at risk

November 17, 2011

Some stents that keep blood vessels open to treat heart disease are poorly designed to resist shortening, according to publications in the Journal of Interventional Cardiology. A case report published in the journal by Dr. ...

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.